Alnylam Pharma Commences Private Offering Of $500 Mln Of Convertible Senior Notes Due 2028

(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced that it has commenced a private offering of $500 million aggregate principal amount of convertible senior notes due 2028. In connection with this offering, Alnylam expects to grant the initial purchasers of the notes an op https://www.nasdaq.com/articles/alnylam-pharma-commences-private-offering-500-mln-convertible-senior-notes-due-2028